1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition-Text Revision. Washington DC: American Psychiatric Association; 2000.
4. Haavik J, Halmoy A, Lundervold AJ, Fasmer OB. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Expert Rev Neurother 2010;10:1569-1580. PMID:
20925472.
5. Teicher MH. Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry 1995;3:18-35. PMID:
9384925.
6. Alderson RM, Rapport MD, Kasper LJ, Sarver DE, Kofler MJ. Hyperactivity in boys with attention deficit/hyperactivity disorder (ADHD): the association between deficient behavioral inhibition, attentional processes, and objectively measured activity. Child Neuropsychol 2012;18:487-505. PMID:
22117760.
7. Teicher MH, Polcari A, Fourligas N, Vitaliano G, Navalta CP. Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder: a case-control study. BMC Psychiatry 2012;12:190PMID:
23134619.
8. Licht CA, Tryon WW. Are children diagnosed with the combined form of ADHD pervasively hyperactive. Behav Modif 2009;33:655-681. PMID:
19864320.
9. Hauge ER, Berle JO, Oedegaard KJ, Holsten F, Fasmer OB. Nonlinear analysis of motor activity shows differences between schizophrenia and depression: a study using Fourier analysis and sample entropy. PLoS One 2011;6:e16291PMID:
21297977.
10. Johnsen E, Fasmer OB, van Wageningen H, Hugdahl K, Hauge E, Jørgensen HA. The influence of glutaminergic antagonism on motor variability, and comparison to findings in schizophrenia patients. Acta Neuropsychiatr 2013;25:105-112. PMID:
25287312.
11. Berle JO, Hauge ER, Oedegaard KJ, Holsten F, Fasmer OB. Actigraphic registration of motor activity reveals a more structured behavioural pattern in schizophrenia than in major depression. BMC Res Notes 2010;3:149PMID:
20507606.
12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33. quiz 34-57PMID:
9881538.
13. Leiknes KA, Malt U, Malt EA, Leganger S. The Mini-International Neuropsychiatric Interview Plus. Norwegian version. Oslo: Psykosomatisk avdeling, Rikshospitalet; 2005.
14. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389. PMID:
444788.
15. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245-256. PMID:
15841682.
16. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723. PMID:
16585449.
17. Halmoy A, Fasmer OB, Gillberg C, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 2009;13:175-187. PMID:
19372500.
18. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890. PMID:
8494063.
19. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000;157:1873-1875. PMID:
11058490.
20. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPSA: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord 2005;85:3-16. PMID:
15780671.
21. Landaas ET, Halmoy A, Oedegaard KJ, Fasmer OB, Haavik J. The impact of cyclothymic temperament in adult ADHD. J Affect Disord 2012;142:241-247. PMID:
22840630.
22. Akiskal HS, Akiskal K, Allilaire JF, Azorin JM, Bourgeois ML, Sechter D, et al. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study. J Affect Disord 2005;85:29-36. PMID:
15780673.
23. Oedegaard KJ, Neckelmann D, Mykletun A, Dahl AA, Zwart JA, Hagen K, et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006;26:1-6. PMID:
16396660.
24. Nichols SL, Waschbusch DA. A review of the validity of laboratory cognitive tasks used to assess symptoms of ADHD. Child Psychiatry Hum Dev 2004;34:297-315. PMID:
15039603.
25. Van Hilten JJ, Middelkoop HA, Kuiper SI, Kramer CG, Roos RA. Where to record motor activity: an evaluation of commonly used sites of placement for activity monitors. Electroencephalogr Clin Neurophysiol 1993;89:359-362. PMID:
7691576.
26. Littner M, Hirshkowitz M, Davila D, Anderson WM, Kushida CA, Woodson BT, et al. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 2002;25:143-147. PMID:
11902424.
27. Van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 1999;16:505-518. PMID:
10442243.
28. Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 2000;101:E215-E220. PMID:
10851218.
29. Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 2000;278:H2039-H2049. PMID:
10843903.
30. Castellanos FX, Sonuga-Barke EJ, Scheres A, Di Martino A, Hyde C, Walters JR. Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiatry 2005;57:1416-1423. PMID:
15950016.
31. Johansson S, Halleland H, Halmoy A, Jacobsen KK, Landaas ET, Dramsdahl M, et al. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1470-1475. PMID:
18081165.
32. Dickerson JW, Conn PJ. Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease. Neurodegener Dis Manag 2012;2:221-232. PMID:
23526920.
33. Lesch KP, Merker S, Reif A, Novak M. Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. Eur Neuropsychopharmacol 2013;23:479-491. PMID:
22939004.
34. Wood AC, Asherson P, Rijsdijk F, Kuntsi J. Is overactivity a core feature in ADHD? Familial and receiver operating characteristic curve analysis of mechanically assessed activity level. J Am Acad Child Adolesc Psychiatry 2009;48:1023-1030. PMID:
19701105.
35. Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, et al. Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006;2:30PMID:
16925830.
36. Kaiser S, Roth A, Rentrop M, Friederich HC, Bender S, Weisbrod M. Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain Cogn 2008;66:73-82. PMID:
17604894.
37. Woyshville MJ, Lackamp JM, Eisengart JA, Gilliland JA. On the meaning and measurement of affective instability: clues from chaos theory. Biol Psychiatry 1999;45:261-269. PMID:
10023499.
38. MacDonald SW, Nyberg L, Backman L. Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity. Trends Neurosci 2006;29:474-480. PMID:
16820224.
39. MacDonald SW, Cervenka S, Farde L, Nyberg L, Backman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia 2009;47:2299-2304. PMID:
19524093.
40. Kam HJ, Shin YM, Cho SM, Kim SY, Kim KW, Park RW. Development of a decision support model for screening attention-deficit hyperactivity disorder with actigraph-based measurements of classroom activity. Appl Clin Inform 2010;1:377-393. PMID:
23616848.
41. Rapport MD, Bolden J, Kofler MJ, Sarver DE, Raiker JS, Alderson RM. Hyperactivity in boys with attention-deficit/hyperactivity disorder (ADHD): a ubiquitous core symptom or manifestation of working memory deficits. J Abnorm Child Psychol 2009;37:521-534. PMID:
19083090.
42. Dane AV, Schachar RJ, Tannock R. Does actigraphy differentiate ADHD subtypes in a clinical research setting. J Am Acad Child Adolesc Psychiatry 2000;39:752-760. PMID:
10846310.
43. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE Jr. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 1983;40:681-687. PMID:
6847335.
44. Tsujii N, Okada A, Kaku R, Kuriki N, Hanada K, Matsuo J, et al. Association between activity level and situational factors in children with attention deficit/hyperactivity disorder in elementary school. Psychiatry Clin Neurosci 2007;61:181-185. PMID:
17362436.
45. Teicher MH, Ito Y, Glod CA, Barber NI. Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 1996;35:334-342. PMID:
8714322.
46. Ginsberg Y, Hirvikoski T, Grann M, Lindefors N. Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. Eur Arch Psychiatry Clin Neurosci 2012;262:705-724. PMID:
22526730.
47. Lis S, Baer N, Stein-en-Nosse C, Gallhofer B, Sammer G, Kirsch P. Objective measurement of motor activity during cognitive performance in adults with attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 2010;122:285-294. PMID:
20199487.
48. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK, Van Someren EJ. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 2007;30:433-442. PMID:
17520787.
49. Porrino LJ, Rapoport JL, Behar D, Ismond DR, Bunney WE Jr. A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. Arch Gen Psychiatry 1983;40:688-693. PMID:
6847336.
50. Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T. Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. J Child Adolesc Psychopharmacol 2011;21:433-444. PMID:
22040189.